High Tower Advisors, LLC Zoetis Inc. Transaction History

High Tower Advisors, LLC

$68.3 Billion
Q3 2024

A detailed history of High Tower Advisors, LLC transactions in Zoetis Inc. stock. As of the latest transaction made, High Tower Advisors, LLC holds 373,118 shares of ZTS stock, worth $65.5 Million. This represents 0.11% of its overall portfolio holdings.

Number of Shares

373,118

Previous 386,765 3.53%

Holding current value

$65.5 Million

Previous $67 Million 8.72%

% of portfolio

0.11%

Previous 0.1%

29 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Nov 14, 2024	SELL	$172.58 - $196.48 $2.36 Million - $2.68 Million	-13,647 Reduced 3.53%	373,118 $72.9 Million
Q2 2024 Aug 13, 2024	SELL	$145.54 - $178.83 $2.66 Million - $3.26 Million	-18,253 Reduced 4.51%	386,765 $67 Million
Q1 2024 May 06, 2024	BUY	$165.67 - $199.94 $412,683 - $498,050	2,491 Added 0.62%	405,018 $68.5 Million
Q4 2023 Feb 12, 2024	SELL	$151.44 - $200.09 $3.97 Million - $5.25 Million	-26,245 Reduced 6.12%	402,527 $79.4 Million
Q3 2023 Nov 08, 2023	BUY	$167.14 - $192.77 $4.88 Million - $5.63 Million	29,220 Added 7.31%	428,772 $74.6 Million
Q2 2023 Aug 14, 2023	BUY	$160.94 - $186.23 $4.01 Million - $4.64 Million	24,924 Added 6.65%	399,552 $68.8 Million
Q1 2023 May 11, 2023	SELL	$145.48 - $175.02 $3.16 Million - $3.8 Million	-21,720 Reduced 5.48%	374,628 $62.4 Million
Q4 2022 Feb 08, 2023	SELL	$131.14 - $157.47 $2.41 Million - $2.9 Million	-18,402 Reduced 4.44%	396,348 $58.1 Million
Q3 2022 Nov 09, 2022	BUY	$148.29 - $182.55 $253,872 - $312,525	1,712 Added 0.41%	414,750 $61.5 Million
Q2 2022 Aug 10, 2022	SELL	$155.97 - $200.09 $3.62 Million - $4.65 Million	-23,220 Reduced 5.32%	413,038 $71 Million
Q1 2022 May 12, 2022	SELL	$181.39 - $234.03 $1.27 Million - $1.64 Million	-7,025 Reduced 1.58%	436,258 $82.4 Million
Q4 2021 Feb 10, 2022	BUY	$193.69 - $247.03 $3.73 Million - $4.76 Million	19,268 Added 4.54%	443,283 $108 Million
Q3 2021 Nov 12, 2021	BUY	$189.29 - $209.69 $4.41 Million - $4.89 Million	23,316 Added 5.82%	424,015 $82.3 Million
Q2 2021 Aug 06, 2021	BUY	$155.9 - $187.99 $2.23 Million - $2.69 Million	14,310 Added 3.7%	400,699 $74.7 Million
Q1 2021 May 10, 2021	BUY	$144.0 - $169.39 $6.94 Million - $8.16 Million	48,161 Added 14.24%	386,389 $60.9 Million
Q3 2020 Nov 13, 2020	BUY	$137.1 - $165.37 $1.08 Million - $1.3 Million	7,853 Added 2.38%	338,228 $55.9 Million
Q2 2020 Aug 10, 2020	BUY	$111.92 - $142.53 $6.2 Million - $7.9 Million	55,438 Added 20.16%	330,375 $45.3 Million
Q1 2020 May 21, 2020	BUY	$92.66 - $144.94 $175,590 - $274,661	1,895 Added 0.69%	274,937 $32.4 Million
Q4 2019 Feb 14, 2020	BUY	$116.25 - $133.25 $586,713 - $672,512	5,047 Added 1.88%	273,042 $36.1 Million
Q3 2019 Nov 12, 2019	BUY	$112.57 - $128.43 $709,866 - $809,879	6,306 Added 2.41%	267,995 $33.3 Million
Q2 2019 Aug 13, 2019	BUY	$97.98 - $114.28 $564,462 - $658,367	5,761 Added 2.25%	261,689 $29.7 Million
Q1 2019 May 15, 2019	SELL	$81.56 - $100.67 $10.2 Million - $12.6 Million	-125,081 Reduced 32.83%	255,928 $25.8 Million
Q4 2018 Feb 14, 2019	SELL	$79.28 - $95.27 $152,534 - $183,299	-1,924 Reduced 0.5%	381,009 $32.6 Million
Q3 2018 Nov 09, 2018	BUY	$83.5 - $93.23 $12.5 Million - $14 Million	150,098 Added 64.47%	382,933 $35 Million
Q2 2018 Aug 14, 2018	SELL	$79.9 - $89.2 $467,894 - $522,355	-5,856 Reduced 2.45%	232,835 $19.9 Million
Q1 2018 May 15, 2018	BUY	$71.51 - $84.69 $1.58 Million - $1.87 Million	22,061 Added 10.18%	238,691 $19.9 Million
Q4 2017 Feb 14, 2018	BUY	$63.24 - $72.8 $988,125 - $1.14 Million	15,625 Added 7.77%	216,630 $15.6 Million
Q3 2017 Nov 14, 2017	BUY	$59.73 - $65.4 $657,030 - $719,400	11,000 Added 5.79%	201,005 $12.8 Million
Q2 2017 Aug 14, 2017	BUY	N/A	190,005	190,005 $11.8 Million

Others Institutions Holding ZTS

# of Institutions

1,956

Shares Held

412M

Call Options Held

1.02M

Put Options Held

1.09M

View Full List

About Zoetis Inc.

Ticker ZTS
Exchange NYSE
Sector Healthcare
Industry Drug Manufacturers—Specialty & Generic
Shares Outstandng 468,139,008
Market Cap $82.2B
Description
Zoetis Inc. discovers, develops, manufactures, and commercializes animal health medicines, vaccines, and diagnostic products in the United States and internationally. It commercializes products primarily across species, including livestock, such as cattle, swine, poultry, fish, and sheep; and companion animals comprising dogs, cats, and horses. ...

More about ZTS

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of High Tower Advisors, LLC, based on Form 13F filings with the SEC.

News

Stay updated on High Tower Advisors, LLC with notifications on news.

Account

High Tower Advisors, LLC Zoetis Inc. Transaction History